Munich, Germany

Ludwig Kuhlmann

This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ludwig Kuhlmann. Retrieved from https://idiyas.com/inventor/ludwig-kuhlmann-krd92h0o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 409(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ludwig Kuhlmann

Introduction

Ludwig Kuhlmann, based in Flörsheim am Main, Germany, is an eminent inventor known for his contributions to the field of biotechnology. With a focus on creating innovative solutions that enhance medical treatments, he holds one notable patent that showcases his ingenuity and expertise.

Latest Patents

Kuhlmann is credited with a patent titled “Bispecific and Oligospecific Mono-and Oligovalent Receptors.” This inventive work pertains to the development of bispecific and oligospecific receptors, which are engineered through gene manipulation. By fusing DNA that encodes for F(ab) fragments of antibodies with different specificities, he has made strides in targeted therapy. The invention emphasizes a dual specificity: one directed towards tumor-associated antigens located on cell membranes or in the interstitium and the other targeting various ligands that interact with complexing agents. This innovative approach enables enhanced binding capabilities and has potential applications in combating cancer.

Career Highlights

Ludwig Kuhlmann has made significant advancements in the biotechnology sector. He is associated with Behringwerke Aktiengesellschaft, a company renowned for its commitment to developing innovative medical solutions. His work in receptor engineering not only reflects his expertise but also signifies a step forward in therapeutic applications.

Collaborations

Kuhlmann has collaborated with prominent colleagues in the field, including Klaus Bosslet and Peter Hermentin. Their joint efforts have contributed to advancing biotechnological innovations, highlighting the importance of teamwork in scientific research and development.

Conclusion

In conclusion, Ludwig Kuhlmann exemplifies the spirit of innovation in the realm of biotechnology. His patent on bispecific and oligospecific receptors marks a significant contribution to medical science, paving the way for future developments and collaborations in the industry. His collaborative spirit and dedication to enhancing therapeutic techniques demonstrate the impactful role of inventors in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…